Delayed Administration of Tat-HA-NR2B9c Promotes Recovery After Stroke in Rats

Stroke. 2015 May;46(5):1352-8. doi: 10.1161/STROKEAHA.115.008886. Epub 2015 Apr 7.

Abstract

Background and purpose: Previous studies reported that Tat-NR2B9c, a peptide disrupting the N-methyl-d-aspartate receptor-postsynaptic density protein-95 interaction, reduced ischemic damage in the acute phase after stroke. However, its effect in the subacute phase is unknown. The aim of this study is to determine whether disrupting the N-methyl-d-aspartate receptor-postsynaptic density protein-95 interaction in the subacute phase promotes recovery after stroke.

Methods: Studies were performed on Sprague-Dawley rats or nNOS(-/-) mice, and experimental ischemic stroke was induced by middle cerebral artery occlusion. Animals were treated with drugs starting at day 4 after ischemia. Sensorimotor functions and spatial learning and memory ability were assessed after drug treatment. Then, rats were euthanized for morphological observation and biochemical tests.

Results: Disrupting the N-methyl-d-aspartate receptor-postsynaptic density protein-95 interaction with Tat-HA-NR2B9c significantly ameliorated the ischemia-induced impairments of spatial memory and sensorimotor functions in rats during subacute stage but did not improve stroke outcome in nNOS(-/-) mice. Consistent with the functional recovery, Tat-HA-NR2B9c substantially increased neurogenesis in the dentate gyrus and dendritic spine density of mature neurons in the motor cortex of rats, meanwhile, reversed the ischemia-induced formation of S-nitrosylation-cyclin-dependent kinase 5 and increased cyclin-dependent kinase 5 activity in ipsilateral hippocampus. However, directly blocking N-methyl-d-aspartate receptors with MK-801 or Ro 25-6981 did not show the beneficial effects above.

Conclusions: Dissociating N-methyl-d-aspartate receptor-postsynaptic density protein-95 coupling by Tat-HA-NR2B9c in the subacute phase after stroke promotes functional recovery, probably because of that it increases neurogenesis and dendritic spine density of mature neurons via regulating cyclin-dependent kinase 5 in the ischemic brain.

Keywords: Tat-NR2B9c; cyclin-dependent kinase 5; nitrosation; regeneration; stroke.

Publication types

  • Research Support, Non-U.S. Gov't
  • Retracted Publication

MeSH terms

  • Animals
  • Brain Ischemia / drug therapy
  • Brain Ischemia / pathology
  • Cognition / drug effects
  • Cyclin-Dependent Kinase 5 / metabolism
  • Dendritic Spines / ultrastructure
  • Dentate Gyrus / pathology
  • Disks Large Homolog 4 Protein
  • Intracellular Signaling Peptides and Proteins / antagonists & inhibitors
  • Male
  • Maze Learning / drug effects
  • Membrane Proteins / antagonists & inhibitors
  • Motor Cortex / pathology
  • Neurogenesis / drug effects
  • Neuroprotective Agents / administration & dosage
  • Neuroprotective Agents / therapeutic use*
  • Nitric Oxide Synthase Type I / metabolism
  • Peptides / administration & dosage
  • Peptides / therapeutic use*
  • Psychomotor Performance / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Recovery of Function
  • Sensation / drug effects
  • Stroke / drug therapy*
  • Stroke / prevention & control

Substances

  • Disks Large Homolog 4 Protein
  • Dlg4 protein, rat
  • Intracellular Signaling Peptides and Proteins
  • Membrane Proteins
  • Neuroprotective Agents
  • Peptides
  • Tat-NR2B9c
  • Nitric Oxide Synthase Type I
  • Cyclin-Dependent Kinase 5